Contributed by Anthony J. Demetris, M.D.
PATIENT HISTORY:
Per referral report, the patient is a 58 year-old obese female with Type II Diabetes Mellitus who presented with jaundice and marked pruritus. Her family history reveals a son with Crohn's Disease. She is currently taking Glucophage and Premarin and denies any alcohol intake. Transfusion history is positive for one transfusion in 1970. Review of outside material. The liver injury tests show marked elevations of gamma glutamyltranspeptidase and alkaline phosphatase, but an ERCP was apparently without abnormalities. Tests for viral hepatitis types B and C were negative.

Final Diagnosis (Case 45)

LIVER, NEEDLE BIOPSY -
  1. ACTIVE, PREDOMINANTLY MICRONODULAR CIRRHOSIS, MOST CONSISTENT WITH A "BILIARY" ETIOLOGY(see microscopic description).

Previous Biopsies on this Patient:
None

TPIS Related Resources:
Modified Knodell Scoring
Liver Transplant Topics


Gross Description - Case 45


The specimen consists of four (4) consult slides with an accompanying surgical pathology report.


Microscopic Description - Case 45


(1 H&E, 1 Trichrome, 1 Iron, 1 Reticulin) The normal lobular architecture is replaced by an active, predominantly micronodular cirrhosis. The normal spatial relationship between the portal tracts and central veins has been disrupted in most areas and the trichrome stain shows nodules surrounded on all four sides by fibrosis. As always, a histopathologic diagnosis of cirrhosis should be clinically confirmed by searching for portal hypertension and other stigmata of chronic liver disease.

Remnants of the portal tracts within the fibrous septae show marked bile duct proliferation, accompanied by a largely acute inflammatory cell infiltrate. No florid or granulomatous duct destructive lesions are seen. No definite fibro-obliterative duct lesions are identified.

At the interface zone, there is marked cholangiolar proliferation and acute cholangiolitis. Periportal hepatocytes are swollen and show cholatestasis-type changes. No prominent pigment deposition or ground glass cells are seen. No significant dysplasia is appreciated. There is mild, predominantly macrovesicular steatosis. A rare periseptal hepatocyte contains Mallory's-like hyaline. There are no increased iron stores present.

Overall, the histopathological changes are indicative of chronic liver disease with advanced architectural distortion, that has a distinct "biliary" appearance. This contention is supported by the marked ductular proliferation, the portal and periportal neutrophilia, and the cholatestasis-type changes in the periportal regions and the marked elevation of the alkaline phosphatase and gamma glutamyltranspeptidase. Possibilities would include partial and/or intermittent biliary tract obstruction or stricturing, such as might be seen with primary sclerosing cholangitis, a biliary tract neoplasm or other mechanical problem, such as a biliary tract stone. Primary biliary cirrhosis is unlikely because of the intact small bile ducts, lack of non-suppurative cholangitis and the negative AMA.

However, this case is somewhat puzzling because an ERCP with contrast injection of the biliary tree is reportedly normal. If indeed biliary mass lesions and obstructive cholangiopathy have been confidently excluded, other possibilities for the histopathologic changes would include an autoimmune hepatitis. Anti-nuclear antibody, anti-neutrophil cytoplasmic antibodies(ANCA) and anti-liver membrane protein(LMP) antibody testing would provide other useful information. Lastly, if all of these diagnoses have been excluded, it is possible but not likely, that the precursor lesion was non-alcoholic steatohepatitis. I look forward to any follow-up in this case.


Please mail comments, corrections or suggestions to the TPIS administration at the UPMC.